Application of five risk stratification tools for syncope in older adults
Objective Treatment of syncope in older adults places a burden on healthcare systems. We used five risk stratification tools to predict short-term adverse outcomes in older patients with syncope. Methods This was a retrospective analysis of patients with syncope (age ≥60 years) in the emergency depa...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-01-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605231220894 |
| _version_ | 1797361401038110720 |
|---|---|
| author | Hong Mu Jiexin Liu Cheng Huang Hefei Tang Sisi Li Chang Dong Tiecheng Yang Limin Liu Bin Xu |
| author_facet | Hong Mu Jiexin Liu Cheng Huang Hefei Tang Sisi Li Chang Dong Tiecheng Yang Limin Liu Bin Xu |
| author_sort | Hong Mu |
| collection | DOAJ |
| description | Objective Treatment of syncope in older adults places a burden on healthcare systems. We used five risk stratification tools to predict short-term adverse outcomes in older patients with syncope. Methods This was a retrospective analysis of patients with syncope (age ≥60 years) in the emergency department of an urban academic hospital. The data were evaluated using the Risk Stratification of Syncope in the Emergency Department (ROSE), San Francisco Syncope Rule (SFSR), FAINT, Canadian Syncope Risk Score (CSRS), and Boston Syncope Criteria (BSC) tools. Sensitivity, specificity, accuracy, positive and negative predictive value (NPV), and positive and negative likelihood ratios of each tool were calculated and compared for adverse events within 1 month. Results In total, 221 patients (average age 75.6 years) were analyzed. Fifty-nine patients (26.7%) had experienced an adverse event within 1 month. For the ROSE, SFSR, FAINT, CSRS and BSC tools, sensitivities were 81.3%, 76.3%, 93.2%, 71.2%, and 94.9%, specificities were 88.3%, 87.7%, 56.8%, 71.6%, and 67.3%, and NPVs were 92.9%, 91.0%, 95.8%, 87.2%, and 97.3%, respectively. Conclusion The five assessed tools could be useful for physicians in screening older patients with syncope for the risk of short-term adverse events, according to the patient’s actual situation. |
| first_indexed | 2024-03-08T15:53:10Z |
| format | Article |
| id | doaj.art-f003e5dc9e2f40bca079738e8bf5f210 |
| institution | Directory Open Access Journal |
| issn | 1473-2300 |
| language | English |
| last_indexed | 2024-03-08T15:53:10Z |
| publishDate | 2024-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj.art-f003e5dc9e2f40bca079738e8bf5f2102024-01-09T04:03:40ZengSAGE PublishingJournal of International Medical Research1473-23002024-01-015210.1177/03000605231220894Application of five risk stratification tools for syncope in older adultsHong MuJiexin LiuCheng HuangHefei TangSisi LiChang DongTiecheng YangLimin LiuBin XuObjective Treatment of syncope in older adults places a burden on healthcare systems. We used five risk stratification tools to predict short-term adverse outcomes in older patients with syncope. Methods This was a retrospective analysis of patients with syncope (age ≥60 years) in the emergency department of an urban academic hospital. The data were evaluated using the Risk Stratification of Syncope in the Emergency Department (ROSE), San Francisco Syncope Rule (SFSR), FAINT, Canadian Syncope Risk Score (CSRS), and Boston Syncope Criteria (BSC) tools. Sensitivity, specificity, accuracy, positive and negative predictive value (NPV), and positive and negative likelihood ratios of each tool were calculated and compared for adverse events within 1 month. Results In total, 221 patients (average age 75.6 years) were analyzed. Fifty-nine patients (26.7%) had experienced an adverse event within 1 month. For the ROSE, SFSR, FAINT, CSRS and BSC tools, sensitivities were 81.3%, 76.3%, 93.2%, 71.2%, and 94.9%, specificities were 88.3%, 87.7%, 56.8%, 71.6%, and 67.3%, and NPVs were 92.9%, 91.0%, 95.8%, 87.2%, and 97.3%, respectively. Conclusion The five assessed tools could be useful for physicians in screening older patients with syncope for the risk of short-term adverse events, according to the patient’s actual situation.https://doi.org/10.1177/03000605231220894 |
| spellingShingle | Hong Mu Jiexin Liu Cheng Huang Hefei Tang Sisi Li Chang Dong Tiecheng Yang Limin Liu Bin Xu Application of five risk stratification tools for syncope in older adults Journal of International Medical Research |
| title | Application of five risk stratification tools for syncope in older adults |
| title_full | Application of five risk stratification tools for syncope in older adults |
| title_fullStr | Application of five risk stratification tools for syncope in older adults |
| title_full_unstemmed | Application of five risk stratification tools for syncope in older adults |
| title_short | Application of five risk stratification tools for syncope in older adults |
| title_sort | application of five risk stratification tools for syncope in older adults |
| url | https://doi.org/10.1177/03000605231220894 |
| work_keys_str_mv | AT hongmu applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT jiexinliu applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT chenghuang applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT hefeitang applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT sisili applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT changdong applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT tiechengyang applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT liminliu applicationoffiveriskstratificationtoolsforsyncopeinolderadults AT binxu applicationoffiveriskstratificationtoolsforsyncopeinolderadults |